Insulet Corp
PODD: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$824.00 | Vvcftc | Drxkcljwg |
Insulet Poised to See Strong Growth Thanks to Omnipod 5; Raising Our Fair Value Estimate
Following narrow-moat Insulet's strong finish to 2022, we've modestly raised our fair value estimate to $234 per share, which reflects our expectation that this recent strength should be supported by the on-going the rollout of Omnipod 5 in the United States and impending launches in the United Kingdom and Germany.